Synaptogenix Inc.

NASDAQ: SNPX · Real-Time Price · USD
7.85
1.80 (29.86%)
At close: Jun 30, 2025, 3:59 PM

Synaptogenix Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 10.27K 10.27K 10.27K 10.27K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
2.49K 3.89K 3.93K 5.65K 6.06K 4.66K 4.97K 4.74K 4.39K 5.71K 5.43K 5.18K 5.04K 4.97K 3.73K 2.49K 1.25K
Gross Profit
-1.32K -2.72K 6.35K 4.63K 4.22K 5.62K -4.97K -4.74K -4.39K -5.71K -5.43K -5.18K -5.04K -4.97K -3.73K -2.49K -1.25K
Operating Income
-5.12M -6.81M -6.76M -6.17M -493.15K -1.72M -5.48M -7.88M -15.77M -16.13M -14.48M -14.24M -12.73M -12.61M -11.34M -12.67M -13.24M
Interest Income
994.82K 1.28M 1.37M 1.62M 1.72M 1.65M 1.52M 1.11M 726.79K 335.04K 192.34K 54.06K 10.9K 7.11K 4.59K 8.94K 83.25K
Pretax Income
-12.18M -12.77M -8.22M -1.71M -4.53M -6.04M -560.19K -4.35M -4.01M -5.57M -14.29M -14.19M -12.73M -12.61M -11.34M -12.68M -13.32M
Net Income
-12.39M -12.77M -8.22M -1.71M -4.53M -6.04M -560.19K -4.49M -4.19M -5.76M -14.48M -14.24M -12.74M -12.61M -11.34M -12.68M -13.32M
Selling & General & Admin
5.14M 5.21M 5.01M 5.09M 5.37M 6.34M 9.26M 9.73M 10.06M 9.81M 8.21M 8.62M 8.07M 8.28M 6.3M 6.38M 7.48M
Research & Development
1.05M 1.6M 1.75M 1.74M 1.71M 1.97M 2.81M 4.08M 5.72M 6.32M 6.27M 5.63M 4.67M 4.34M 5.04M 4.61M 4.23M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
6.19M 6.81M 6.76M 6.83M 7.08M 8.31M 12.07M 13.81M 15.77M 16.13M 14.48M 14.25M 12.75M 12.62M 11.34M 10.99M 11.7M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a -1.4K -2.61K -2.61K -2.61K -1.21K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
5.12M 6.81M 6.76M 6.83M 7.08M 8.31M 12.07M 13.81M 15.77M 16.13M 14.48M 14.25M 12.75M 12.62M 11.34M 10.99M 11.7M
Income Tax Expense
-789.91B -789.91B n/a -1.12M -7.24M -7.24M -7.24M -5.98M 185.22K 189.83K 192.34K 54.06K 10.9K 4.66K 2.05K 6.4K 80.71K
Shares Outstanding (Basic)
1.39M 1.23M 1.25M 1.07M 1.04M 686K 428.2K 118K 259K 290K 279K 277K 277K 271K 247K 158K 118K
Shares Outstanding (Diluted)
1.39M 1.23M 1.32M 1.21M 1.04M 847.16K 428.2K 294.5K 300.1K 282.78K 279.52K 278.38K 277.57K 271.99K 247.86K 158.85K 118.76K
EPS (Basic)
-10.22 -10.75 -7.62 -3.88 -37.37 -43.55 -26.66 -36.65 -15.46 -20.68 -51.69 -52.67 -53.63 -68.38 -126.68 -204.66 -248.51
EPS (Diluted)
-10.3 -10.75 -7.62 -3.88 -37.37 -43.55 -26.66 -36.65 -15.48 -20.7 -51.71 -52.69 -53.63 -68.38 -126.68 -204.87 -248.72
EBITDA
-5.12M -6.81M -6.76M -6.83M -7.08M -8.31M -12.06M -13.8M -15.77M -16.13M -14.48M -14.24M -12.74M -12.61M -11.34M -10.99M -11.7M
EBIT
-5.12M -6.81M -6.76M -6.83M -7.08M -8.31M -12.07M -13.81M -15.77M -16.13M -14.48M -14.25M -12.75M -12.62M -11.34M -10.99M -11.7M
Depreciation & Amortization
4.18K 5.58K 5.62K 5.65K 6.06K 6.35K 6.66K 6.43K 6.08K 5.71K 5.43K 5.18K 5.04K 4.97K 4.96K 4.95K 4.95K